{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:46:43Z","timestamp":1793144803662,"version":"4.5.0"},"reference-count":151,"publisher":"Bentham Science Publishers Ltd.","issue":"11","funder":[{"DOI":"10.13039\/501100001843","name":"SERB-DST, New Delhi, through the Early Career Research","doi-asserted-by":"publisher","award":["ECR\/20l5\/000257"],"award-info":[{"award-number":["ECR\/20l5\/000257"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>A high-fat diet with appropriate protein and low carbohydrate content, widely known as the ketogenic diet (KD), is considered as an effective non-pharmacotherapeutic treatment option for certain types of epilepsies. Several preclinical and clinical studies have been carried out to elucidate its mechanism of antiepileptic action. Ketone bodies produced after KD's breakdown interact with cellular excito-inhibitory processes and inhibit abnormal neuronal firing. The generated ketone bodies decrease glutamate release by inhibiting the vesicular glutamate transporter 1 and alter the transmembrane potential by hyperpolarization. Apart from their effect on the well-known pathogenic mechanisms of epilepsy, some recent studies have shown the interaction of KD metabolites with novel neuronal targets, particularly adenosine receptors, adenosine triphosphate-sensitive potassium channel, mammalian target of rapamycin, histone deacetylase, hydroxycarboxylic acid receptors, and the NLR family pyrin domain containing 3 inflammasomes to suppress seizures. The role of KD in augmenting gut microbiota as a potential mechanism for epileptic seizure suppression has been established. Furthermore, some recent findings also support the beneficial effect of KD against epilepsy- associated comorbidities. Despite several advantages of the KD in epilepsy management, its use is also associated with a wide range of side effects. Hypoglycemia, excessive ketosis, acidosis, renal stones, cardiomyopathies, and other metabolic disturbances are the primary adverse effects observed with the use of KD. However, in some recent studies, modified KD has been tested with lesser side effects and better tolerability. The present review discusses the molecular mechanism of KD and its role in managing epilepsy and its associated comorbidities.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570159x20666220420130109","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T07:20:56Z","timestamp":1650612056000},"page":"2034-2049","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Insights into the Cellular Interactions and Molecular Mechanisms of Ketogenic Diet for Comprehensive Management of Epilepsy"],"prefix":"10.2174","volume":"20","author":[{"given":"Damanpreet","family":"Singh","sequence":"first","affiliation":[{"name":"Pharmacology and Toxicology Laboratory, Dietetics and Nutrition Technology Division, CSIR- Institute of Himalayan Bioresource Technology, Palampur 176061, Himachal Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Laboratory, Dietetics and Nutrition Technology Division, CSIR- Institute of Himalayan Bioresource Technology, Palampur 176061, Himachal Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Kumari","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Laboratory, Dietetics and Nutrition Technology Division, CSIR- Institute of Himalayan Bioresource Technology, Palampur 176061, Himachal Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.3390\/ijms21228573","volume":"21","author":"Zavala-Tecuapetla C.","year":"2020","unstructured":"Zavala-Tecuapetla C.; Cuellar-Herrera M.; Luna-Munguia H.; Insights into potential targets for therapeutic intervention in epilepsy. Int J Mol Sci 2020,21(22),8573","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1542\/peds.2010-1371","volume":"129","author":"Russ S.A.","year":"2012","unstructured":"Russ S.A.; Larson K.; Halfon N.; A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012,129(2),256-264","journal-title":"Pediatrics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/157015909788848857","volume":"7","author":"St Louis E.K.","year":"2009","unstructured":"St Louis E.K.; Minimizing AED adverse effects: Improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 2009,7(2),106-114","journal-title":"Curr Neuropharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/157015909788848866","volume":"7","author":"St Louis E.K.","year":"2009","unstructured":"St Louis E.K.; Rosenfeld W.E.; Bramley T.; Antiepileptic drug monotherapy: The initial approach in epilepsy management. Curr Neuropharmacol 2009,7(2),77-82","journal-title":"Curr Neuropharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","volume":"44","author":"Sankaraneni R.","year":"2015","unstructured":"Sankaraneni R.; Lachhwani D.; Antiepileptic drugs--a review. Pediatr Ann 2015,44(2),e36-e42","journal-title":"Pediatr Ann"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.1528-1157.2003.32702.x","volume":"44","author":"Luszczki J.J.","year":"2003","unstructured":"Luszczki J.J.; Borowicz K.K.; Swiader M.; Czuczwar S.J.; Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: An isobolographic analysis. Epilepsia 2003,44(4),489-499","journal-title":"Epilepsia"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","volume":"43","author":"Matsuo F.","year":"1993","unstructured":"Matsuo F.; Bergen D.; Faught E.; Messenheimer J.A.; Dren A.T.; Rudd G.D.; Lineberry C.G.; Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993,43(11),2284-2291","journal-title":"Neurology"},{"key":"ref=8","first-page":"31","volume":"14","author":"Elshorbagy H.H.","year":"2020","unstructured":"Elshorbagy H.H.; Barseem N.F.; Suliman H.A.; Talaat E.; AlSHOKARY, A.H.; Abdelghani, W.E.; Abdulsamea, S.E.; Maksoud, Y.H.A.; Azab, S.M.; Elsadek, A.E.; Nour El Din, D.M. The impact of antiepileptic drugs on thyroid function in children with Epilepsy: New versus old. Iran J Child Neurol 2020,14(1),31-41","journal-title":"Iran J Child Neurol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"Kwan P.","year":"2010","unstructured":"Kwan P.; Arzimanoglou A.; Berg A.T.; Brodie M.J.; Allen Hauser W.; Mathern G.; Mosh&#xE9; S.L.; Perucca E.; Wiebe S.; French J.; Def-inition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010,51(6),1069-1077","journal-title":"Epilepsia"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.115.230151","volume":"357","author":"Reddy D.S.","year":"2016","unstructured":"Reddy D.S.; Golub V.M.; The pharmacological basis of cannabis therapy for epilepsy. J Pharmacol Exp Ther 2016,357(1),45-55","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.2174\/1381612823666171009144400","volume":"23","author":"Guekht A.","year":"2017","unstructured":"Guekht A.; Epilepsy, comorbidities and treatments. Curr Pharm Des 2017,23(37),5702-5726","journal-title":"Curr Pharm Des"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11910-020-01061-3","volume":"20","author":"Dawit S.","year":"2020","unstructured":"Dawit S.; Crepeau A.Z.; When drugs do not work: Alternatives to antiseizure medications. Curr Neurol Neurosci Rep 2020,20(9),37","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-3101(24)00055-0","volume":"44","author":"Swink T.D.","year":"1997","unstructured":"Swink T.D.; Vining E.P.; Freeman J.M.; The ketogenic diet: 1997. Adv Pediatr 1997,44,297-329","journal-title":"Adv Pediatr"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0972-2327.85870","volume":"14","author":"Saxena V.S.","year":"2011","unstructured":"Saxena V.S.; Nadkarni V.V.; Nonpharmacological treatment of epilepsy. Ann Indian Acad Neurol 2011,14(3),148-152","journal-title":"Ann Indian Acad Neurol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4140\/TCP.n.2017.388","volume":"32","author":"Walczyk T.","year":"2017","unstructured":"Walczyk T.; Wick J.Y.; The ketogenic diet: Making a comeback. Consult Pharm 2017,32(7),388-396","journal-title":"Consult Pharm"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-030-67403-8_8","author":"Boison D.","year":"2021","unstructured":"Boison D.; In: Inflammation and Epilepsy: New Vistas 2021,185-201","journal-title":"In: Inflammation and Epilepsy: New Vistas"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2377-11-10","volume":"11","author":"de Kinderen R.J.","year":"2011","unstructured":"de Kinderen R.J.; Lambrechts D.A.; Postulart D.; Kessels A.G.; Hendriksen J.G.; Aldenkamp A.P.; Evers S.M.; Majoie M.H.; Re-search into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: Design of a random-ized controlled trial. BMC Neurol 2011,11(1),10","journal-title":"BMC Neurol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","volume":"70","author":"Veech R.L.","year":"2004","unstructured":"Veech R.L.; The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: Ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004,70(3),309-319","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/epi.16364","volume":"60","author":"Kverneland M.","year":"2019","unstructured":"Kverneland M.; Taub&#xF8;ll E.; Molteberg E.; Veier&#xF8;d M.B.; Selmer K.K.; Nakken K.O.; Iversen P.O.; Pharmacokinetic interaction be-tween modified Atkins diet and antiepileptic drugs in adults with drug-resistant epilepsy. Epilepsia 2019,60(11),2235-2244","journal-title":"Epilepsia"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/epi4.12453","volume":"6","author":"Abdelmoity A.T.","year":"2021","unstructured":"Abdelmoity A.T.; Le Pichon J.B.; Abdelmoity S.A.; Sherman A.K.; Hall A.S.; Abdelmoity A.T.; Combined use of the ketogenic diet and vagus nerve stimulation in pediatric drug-resistant epilepsy. Epilepsia Open 2021,6(1),112-119","journal-title":"Epilepsia Open"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0404.2012.01686.x","volume":"127","author":"Lambrechts D.A.J.E.","year":"2013","unstructured":"Lambrechts D.A.J.E.; Bovens M.J.M.; de la Parra N.M.; Hendriksen J.G.M.; Aldenkamp A.P.; Majoie M.J.M.; Ketogenic diet effects on cognition, mood, and psychosocial adjustment in children. Acta Neurol Scand 2013,127(2),103-108","journal-title":"Acta Neurol Scand"},{"key":"ref=22","first-page":"12","volume":"8","author":"Ghazavi A.","year":"2014","unstructured":"Ghazavi A.; Tonekaboni S.H.; Karimzadeh P.; Nikibakhsh A.A.; Khajeh A.; Fayyazi A.; The ketogenic and atkins diets effect on intrac-table epilepsy: A comparison. Iran J Child Neurol 2014,8(3),12-17","journal-title":"Iran J Child Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/nu12061809","volume":"12","author":"Wells J.","year":"2020","unstructured":"Wells J.; Swaminathan A.; Paseka J.; Hanson C.; Efficacy and safety of a ketogenic diet in children and adolescents with refractory epi-lepsy-A review. Nutrients 2020,12(6),1809","journal-title":"Nutrients"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1046\/j.1528-1157.2001.17601.x","volume":"42","author":"Greene A.E.","year":"2001","unstructured":"Greene A.E.; Todorova M.T.; McGowan R.; Seyfried T.N.; Caloric restriction inhibits seizure susceptibility in epileptic EL mice by re-ducing blood glucose. Epilepsia 2001,42(11),1371-1378","journal-title":"Epilepsia"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4103\/1673-5374.241442","volume":"13","author":"Fedorovich S.V.","year":"2018","unstructured":"Fedorovich S.V.; Voronina P.P.; Waseem T.V.; Ketogenic diet versus ketoacidosis: What determines the influence of ketone bodies on neurons? Neural Regen Res 2018,13(12),2060-2063","journal-title":"Neural Regen Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1749-6632.2012.06525.x","volume":"1264","author":"Rothman S.M.","year":"2012","unstructured":"Rothman S.M.; Griffioen K.J.; Wan R.; Mattson M.P.; Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci 2012,1264(1),49-63","journal-title":"Ann N Y Acad Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1507\/endocrj.EJ20-0405","volume":"68","author":"Mao T.","year":"2021","unstructured":"Mao T.; Wei Q.; Zhao F.; Zhang C.; Short-term fasting reshapes fat tissue. Endocr J 2021,68(4),387-398","journal-title":"Endocr J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/nu11040873","volume":"11","author":"Grajower M.M.","year":"2019","unstructured":"Grajower M.M.; Horne B.D.; Clinical management of intermittent fasting in patients with diabetes mellitus. Nutrients 2019,11(4),873","journal-title":"Nutrients"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.0022-3042.2001.00747.x","volume":"80","author":"Lee J.","year":"2002","unstructured":"Lee J.; Seroogy K.B.; Mattson M.P.; Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem 2002,80(3),539-547","journal-title":"J Neurochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"Augustin K.","year":"2018","unstructured":"Augustin K.; Khabbush A.; Williams S.; Eaton S.; Orford M.; Cross J.H.; Heales S.J.R.; Walker M.C.; Williams R.S.B.; Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol 2018,17(1),84-93","journal-title":"Lancet Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1159\/000492091","volume":"48","author":"Sikder K.","year":"2018","unstructured":"Sikder K.; Shukla S.K.; Patel N.; Singh H.; Rafiq K.; High fat diet upregulates fatty acid oxidation and ketogenesis via intervention of PPAR- &#x3B3;. Cell Physiol Biochem 2018,48(3),1317-1331","journal-title":"Cell Physiol Biochem"},{"key":"ref=32","author":"Freeman J.M.","year":"1996","unstructured":"Freeman J.M.; Kelly M.T.; Freeman J.B.; The epilepsy diet treatment: An introduction to the ketogenic diet; 1996"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","volume":"10","author":"Pitk&#xE4;nen A.","year":"2011","unstructured":"Pitk&#xE4;nen A.; Lukasiuk K.; Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011,10(2),173-186","journal-title":"Lancet Neurol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11910-019-0946-7","volume":"19","author":"Weber D.J.","year":"2019","unstructured":"Weber D.J.; Moeller J.J.; J. Epilepsy education: Recent advances and future directions. Curr Neurol Neurosci Rep 2019,19(6),35","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","volume":"69","author":"Quek A.M.","year":"2012","unstructured":"Quek A.M.; Britton J.W.; McKeon A.; So E.; Lennon V.A.; Shin C.; Klein C.; Watson R.E.; Kotsenas A.L.; Lagerlund T.D.; Cas-cino G.D.; Worrell G.A.; Wirrell E.C.; Nickels K.C.; Aksamit A.J.; Noe K.H.; Pittock S.J.; Autoimmune epilepsy: Clinical characteris-tics and response to immunotherapy. Arch Neurol 2012,69(5),582-593","journal-title":"Arch Neurol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnins.2019.00005","volume":"13","author":"D\u2019Andrea Meira I.","year":"2019","unstructured":"D\u2019Andrea Meira I.; Rom&#xE3;o T.T.; Pires do Prado H.J.; Kr&#xFC;ger L.T.; Pires M.E.P.; da Concei&#xE7;&#xE3;o P.O.; Ketogenic diet and epilepsy: What we know so far. Front Neurosci 2019,13,5","journal-title":"Front Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/dmcn.14393","volume":"62","author":"Bjurulf B.","year":"2020","unstructured":"Bjurulf B.; Magnus P.; Hallb&#xF6;&#xF6;k T.; Str&#xF8;mme P.; Potassium citrate and metabolic acidosis in children with epilepsy on the ketogenic diet: A prospective controlled study. Dev Med Child Neurol 2020,62(1),57-61","journal-title":"Dev Med Child Neurol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/jada.2003.50136","volume":"103","author":"Liu Y.M.C.","year":"2003","unstructured":"Liu Y.M.C.; Williams S.; Basualdo-Hammond C.; Stephens D.; Curtis R.; A prospective study: Growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc 2003,103(6),707-712","journal-title":"J Am Diet Assoc"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jamapediatrics.2020.2282","volume":"174","author":"Sondhi V.","year":"2020","unstructured":"Sondhi V.; Agarwala A.; Pandey R.M.; Chakrabarty B.; Jauhari P.; Lodha R.; Toteja G.S.; Sharma S.; Paul V.K.; Kossoff E.; Gulati S.; Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: A randomized clinical trial. JAMA Pediatr 2020,174(10),944-951","journal-title":"JAMA Pediatr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/epi.14457","volume":"59","author":"Kverneland M.","year":"2018","unstructured":"Kverneland M.; Molteberg E.; Iversen P.O.; Veier&#xF8;d M.B.; Taub&#xF8;ll E.; Selmer K.K.; Nakken K.O.; Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial. Epilepsia 2018,59(8),1567-1576","journal-title":"Epilepsia"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1469-8749.1989.tb03973.x","volume":"31","author":"Schwartz R.M.","year":"1989","unstructured":"Schwartz R.M.; Boyes S.; Aynsley-Green A.; Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol 1989,31(2),152-160","journal-title":"Dev Med Child Neurol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpn.2018.11.007","volume":"23","author":"Guzel O.","year":"2019","unstructured":"Guzel O.; Uysal U.; Arslan N.; Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey. Eur J Paediatr Neurol 2019,23(1),143-151","journal-title":"Eur J Paediatr Neurol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2017.10.009","volume":"1678","author":"Wang B.H.","year":"2018","unstructured":"Wang B.H.; Hou Q.; Lu Y.Q.; Jia M.M.; Qiu T.; Wang X.H.; Zhang Z.X.; Jiang Y.; Ketogenic diet attenuates neuronal injury via au-tophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res 2018,1678,106-115","journal-title":"Brain Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1017\/S000711451500313X","volume":"114","author":"Law T.H.","year":"2015","unstructured":"Law T.H.; Davies E.S.; Pan Y.; Zanghi B.; Want E.; Volk H.A.; A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy. Br J Nutr 2015,114(9),1438-1447","journal-title":"Br J Nutr"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroscience.2015.11.029","volume":"313","author":"Maciejak P.","year":"2016","unstructured":"Maciejak P.; Szyndler J.; Turzy\u0144;ska, D.; Sobolewska, A.; Ko\u0142;osowska, K.; Krz\u0105;&#x15B;;cik, P.; P\u0142;a&#x17A;;nik, A. Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypothesis of action. Neuroscience 2016,313,130-148","journal-title":"Neuroscience"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1006\/exnr.1999.7298","volume":"161","author":"Thavendiranathan P.","year":"2000","unstructured":"Thavendiranathan P.; Mendonca A.; Dell C.; Likhodii S.S.; Musa K.; Iracleous C.; Cunnane S.C.; Burnham W.M.; The MCT ketogenic diet: Effects on animal seizure models. Exp Neurol 2000,161(2),696-703","journal-title":"Exp Neurol"},{"key":"ref=47","first-page":"115","volume":"31","author":"Sanya E.O.","year":"2017","unstructured":"Sanya E.O.; Soladoye A.O.; Desalu O.O.; Kolo P.M.; Olatunji L.A.; Olarinoye J.K.; Antiseizure effects of ketogenic diet on seizures induced with pentylenetetrazole, 4-aminopyridine and strychnine in Wistar rats. Niger J Physiol Sci 2017,31(2),115-119","journal-title":"Niger J Physiol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11011-016-9900-4","volume":"32","author":"Zarnowska I.","year":"2017","unstructured":"Zarnowska I.; Luszczki J.J.; Zarnowski T.; Wlaz P.; Czuczwar S.J.; Gasior M.; Proconvulsant effects of the ketogenic diet in electro-shock-induced seizures in mice. Metab Brain Dis 2017,32(2),351-358","journal-title":"Metab Brain Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.expneurol.2011.09.001","volume":"232","author":"Jeong E.A.","year":"2011","unstructured":"Jeong E.A.; Jeon B.T.; Shin H.J.; Kim N.; Lee D.H.; Kim H.J.; Kang S.S.; Cho G.J.; Choi W.S.; Roh G.S.; Ketogenic diet-induced peroxisome proliferator-activated receptor-&#x3B3;; activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol 2011,232(2),195-202","journal-title":"Exp Neurol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13063-017-1918-3","volume":"18","author":"Titre-Johnson S.","year":"2017","unstructured":"Titre-Johnson S.; Schoeler N.; Eltze C.; Williams R.; Vezyroglou K.; McCullagh H.; Freemantle N.; Heales S.; Kneen R.; Marston L.; Martland T.; Nazareth I.; Neal E.; Lux A.; Parker A.; Agrawal S.; Fallon P.; Cross J.H.; Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: Study protocol for a randomised controlled trial. Trials 2017,18(1),195","journal-title":"Trials"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00429-013-0672-x","volume":"220","author":"Lauritzen F.","year":"2015","unstructured":"Lauritzen F.; Eid T.; Bergersen L.H.; Monocarboxylate transporters in temporal lobe epilepsy: Roles of lactate and ketogenic diet. Brain Struct Funct 2015,220(1),1-12","journal-title":"Brain Struct Funct"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"110299","DOI":"10.1016\/j.mehy.2020.110299","volume":"145","author":"Campbell I.","year":"2020","unstructured":"Campbell I.; Campbell H.; Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K\/AKT\/HIF1-a pathway. Med Hypotheses 2020,145,110299","journal-title":"Med Hypotheses"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11011-017-9997-0","volume":"32","author":"Motamedi S.","year":"2017","unstructured":"Motamedi S.; Karimi I.; Jafari F.; The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone. Metab Brain Dis 2017,32(3),651-665","journal-title":"Metab Brain Dis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1111\/j.1528-1167.2011.02981.x","volume":"52","author":"McDaniel S.S.","year":"2011","unstructured":"McDaniel S.S.; Rensing N.R.; Thio L.L.; Yamada K.A.; Wong M.; The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 2011,52(3),e7-e11","journal-title":"Epilepsia"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1871527315666160615022203","volume":"15","author":"Mazumder A.G.","year":"2016","unstructured":"Mazumder A.G.; Padwad Y.S.; Singh D.; Anticancer mammalian target of rapamycin (mTOR) signaling pathway inhibitors: Current sta-tus, challenges and future prospects in management of epilepsy. CNS Neurol Disord Drug Targets 2016,15(8),945-955","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"108916","DOI":"10.1016\/j.jneumeth.2020.108916","volume":"346","author":"Kumari S.","year":"2020","unstructured":"Kumari S.; Sharma P.; Mazumder A.G.; Rana A.K.; Sharma S.; Singh D.; Development and validation of chemical kindling in adult zebrafish: A simple and improved chronic model for screening of antiepileptic agents. J Neurosci Methods 2020,346,108916","journal-title":"J Neurosci Methods"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"a022780","DOI":"10.1101\/cshperspect.a022780","volume":"6","author":"Rogawski M.A.","year":"2016","unstructured":"Rogawski M.A.; L&#xF6;scher W.; Rho J.M.; Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med 2016,6(5),a022780","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","volume":"30","author":"Boison D.","year":"2017","unstructured":"Boison D.; New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol 2017,30(2),187-192","journal-title":"Curr Opin Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1046\/j.1528-1157.2002.47901.x","volume":"43","author":"Rho J.M.","year":"2002","unstructured":"Rho J.M.; Anderson G.D.; Donevan S.D.; White H.S.; Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-&#x3B2;;-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002,43(4),358-361","journal-title":"Epilepsia"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/nutrit\/nuaa112","volume":"79","author":"Neves G.S.","year":"2021","unstructured":"Neves G.S.; Lunardi M.S.; Lin K.; Rieger D.K.; Ribeiro L.C.; Moreira J.D.; Ketogenic diet, seizure control, and cardiometabolic risk in adult patients with pharmacoresistant epilepsy: A review. Nutr Rev 2021,79(8),931-944","journal-title":"Nutr Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.clnu.2019.05.026","volume":"39","author":"Qi X.","year":"2020","unstructured":"Qi X.; Tester R.F.; The \u2018epileptic diet\u2019- ketogenic and\/or slow release of glucose intervention: A review. Clin Nutr 2020,39(5),1324-1330","journal-title":"Clin Nutr"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2018.10.005","volume":"121","author":"Luna-Munguia H.","year":"2019","unstructured":"Luna-Munguia H.; Zestos A.G.; Gliske S.V.; Kennedy R.T.; Stacey W.C.; Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy. Neurobiol Dis 2019,121,177-186","journal-title":"Neurobiol Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12272-019-01196-z","volume":"42","author":"Lee S.E.","year":"2019","unstructured":"Lee S.E.; Lee Y.; Lee G.H.; The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain. Arch Pharm Res 2019,42(12),1031-1039","journal-title":"Arch Pharm Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s11064-017-2253-5","volume":"42","author":"Simeone T.A.","year":"2017","unstructured":"Simeone T.A.; Simeone K.A.; Rho J.M.; Ketone bodies as anti-seizure agents. Neurochem Res 2017,42(7),2011-2018","journal-title":"Neurochem Res"},{"key":"ref=65","author":"Masino S.A.","year":"2012","unstructured":"Masino S.A.; Rho J.M.; Mechanisms of ketogenic diet action. In: Jasper's Basic Mechanisms of the Epilepsies, 4th edition; Noebels, J.L.; Avoli, M.; Rogawski, M.A.; Olsen, R.W.; Delgado-Escueta, A.V., Eds.; National Center for Biotechnology Information (US): Bethesda (MD), 2012"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","volume":"15","author":"Guerriero R.M.","year":"2015","unstructured":"Guerriero R.M.; Giza C.C.; Rotenberg A.; Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep 2015,15(5),27","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.eplepsyres.2014.04.001","volume":"108","author":"DiNuzzo M.","year":"2014","unstructured":"DiNuzzo M.; Mangia S.; Maraviglia B.; Giove F.; Physiological bases of the K+ and the glutamate\/GABA hypotheses of epilepsy. Epilepsy Res 2014,108(6),995-1012","journal-title":"Epilepsy Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eplepsyres.2015.08.005","volume":"117","author":"Yum M.S.","year":"2015","unstructured":"Yum M.S.; Lee, M.; Woo, D.C.; Kim, D.W.; Ko, T.S.; Vel&#xED;\u0161ek, L.; D\u2019Agostino, D.; Planavsky, N.; Lupfer, C.; Kanneganti, T.D.; Kang, S.; Horvath, T.L.; Yum, M.S.; Lee, M.; Woo, D.C.; Kim, D.W.; Ko, T.S.; Vel&#xED;\u0161ek, L. &#x3B2;;-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy. Epilepsy Res 2015,117,125-132","journal-title":"Epilepsy Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","volume":"72","author":"Halassa M.M.","year":"2010","unstructured":"Halassa M.M.; Haydon P.G.; Integrated brain circuits: Astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 2010,72(1),335-355","journal-title":"Annu Rev Physiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuropharm.2015.01.005","volume":"94","author":"Baron A.","year":"2015","unstructured":"Baron A.; Lingueglia E.; Pharmacology of acid-sensing ion channels - Physiological and therapeutical perspectives. Neuropharmacology 2015,94,19-35","journal-title":"Neuropharmacology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12035-014-9014-0","volume":"53","author":"Cao Q.","year":"2016","unstructured":"Cao Q.; Wang W.; Gu J.; Jiang G.; Wang K.; Xu Z.; Li J.; Chen G.; Wang X.; Elevated expression of acid-sensing ion channel 3 inhib-its epilepsy via activation of interneurons. Mol Neurobiol 2016,53(1),485-498","journal-title":"Mol Neurobiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fneur.2019.00155","volume":"10","author":"Zhu F.","year":"2019","unstructured":"Zhu F.; Shan W.; Xu Q.; Guo A.; Wu J.; Wang Q.; Ketone bodies inhibit the opening of acid-sensing ion channels (ASICs) in rat hippo-campal excitatory neurons in vitro. Front Neurol 2019,10,155","journal-title":"Front Neurol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eplepsyres.2009.09.020","volume":"88","author":"Waldbaum S.","year":"2010","unstructured":"Waldbaum S.; Patel M.; Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 2010,88(1),23-45","journal-title":"Epilepsy Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"795259","DOI":"10.1155\/2012\/795259","volume":"2012","author":"Aguiar C.C.","year":"2012","unstructured":"Aguiar C.C.; Almeida A.B.; Ara&#xFA;jo P.V.; de Abreu R.N.; Chaves E.M.; do Vale O.C.; Mac&#xEA;do D.S.; Woods D.J.; Fonteles M.M.; Vasconcelos S.M.; Oxidative stress and epilepsy: Literature review. Oxid Med Cell Longev 2012,2012,795259","journal-title":"Oxid Med Cell Longev"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"745613","DOI":"10.1155\/2015\/745613","volume":"2015","author":"Puttachary S.","year":"2015","unstructured":"Puttachary S.; Sharma S.; Stark S.; Thippeswamy T.; Seizure-induced oxidative stress in temporal lobe epilepsy. BioMed Res Int 2015,2015,745613","journal-title":"BioMed Res Int"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","volume":"72","author":"Borowicz-Reutt K.K.","year":"2020","unstructured":"Borowicz-Reutt K.K.; Czuczwar S.J.; Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep 2020,72(5),1218-1226","journal-title":"Pharmacol Rep"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuint.2011.03.025","volume":"59","author":"Shin E.J.","year":"2011","unstructured":"Shin E.J.; Jeong J.H.; Chung Y.H.; Kim W.K.; Ko K.H.; Bach J.H.; Hong J.S.; Yoneda Y.; Kim H.C.; Role of oxidative stress in epilep-tic seizures. Neurochem Int 2011,59(2),122-137","journal-title":"Neurochem Int"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"H2843","DOI":"10.1152\/ajpheart.01274.2004","volume":"288","author":"Parfenova H.","year":"2005","unstructured":"Parfenova H.; Carratu P.; Tcheranova D.; Fedinec A.; Pourcyrous M.; Leffler C.W.; Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression. Am J Physiol Heart Circ Physiol 2005,288(6),H2843-H2850","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.seizure.2010.12.005","volume":"20","author":"Li G.","year":"2011","unstructured":"Li G.; Bauer S.; Nowak M.; Norwood B.; Tackenberg B.; Rosenow F.; Knake S.; Oertel W.H.; Hamer H.M.; Cytokines and epilepsy. Seizure 2011,20(3),249-256","journal-title":"Seizure"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10863-010-9320-9","volume":"42","author":"Waldbaum S.","year":"2010","unstructured":"Waldbaum S.; Patel M.; Mitochondrial dysfunction and oxidative stress: A contributing link to acquired epilepsy? J Bioenerg Biomembr 2010,42(6),449-455","journal-title":"J Bioenerg Biomembr"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1471-4159.2007.04483.x","volume":"101","author":"Kim D.Y.","year":"2007","unstructured":"Kim D.Y.; Davis L.M.; Sullivan P.G.; Maalouf M.; Simeone T.A.; van Brederode J.; Rho J.M.; Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem 2007,101(5),1316-1326","journal-title":"J Neurochem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"474296","DOI":"10.1155\/2014\/474296","volume":"2014","author":"Paoli A.","year":"2014","unstructured":"Paoli A.; Bianco A.; Damiani E.; Bosco G.; Ketogenic diet in neuromuscular and neurodegenerative diseases. BioMed Res Int 2014,2014,474296","journal-title":"BioMed Res Int"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jnr.20736","volume":"83","author":"Noh H.S.","year":"2006","unstructured":"Noh H.S.; Hah Y.S.; Nilufar R.; Han J.; Bong J.H.; Kang S.S.; Cho G.J.; Choi W.S.; Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res 2006,83(4),702-709","journal-title":"J Neurosci Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2007.12.029","volume":"211","author":"Haces M.L.","year":"2008","unstructured":"Haces M.L.; Hern&#xE1;ndez-Fonseca K.; Medina-Campos O.N.; Montiel T.; Pedraza-Chaverri J.; Massieu L.; Antioxidant capacity contrib-utes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol 2008,211(1),85-96","journal-title":"Exp Neurol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1177\/0271678X15610584","volume":"36","author":"Greco T.","year":"2016","unstructured":"Greco T.; Glenn T.C.; Hovda D.A.; Prins M.L.; Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory com-plex activity. J Cereb Blood Flow Metab 2016,36(9),1603-1613","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1023\/A:1026107405399","volume":"28","author":"Ziegler D.R.","year":"2003","unstructured":"Ziegler D.R.; Ribeiro L.C.; Hagenn M.; Siqueira I.R.; Ara&#xFA;jo E.; Torres I.L.; Gottfried C.; Netto C.A.; Gon&#xE7;alves C.A.; Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 2003,28(12),1793-1797","journal-title":"Neurochem Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","volume":"12","author":"Folbergrov&#xE1; J.","year":"2012","unstructured":"Folbergrov&#xE1; J.; Kunz W.S.; Mitochondrial dysfunction in epilepsy. Mitochondrion 2012,12(1),35-40","journal-title":"Mitochondrion"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/bph.12407","volume":"171","author":"Tinker A.","year":"2014","unstructured":"Tinker A.; Aziz Q.; Thomas A.; The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system. Br J Pharmacol 2014,171(1),12-23","journal-title":"Br J Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0306-4522(01)00473-0","volume":"109","author":"Blondeau N.","year":"2002","unstructured":"Blondeau N.; Widmann C.; Lazdunski M.; Heurteaux C.; Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002,109(2),231-241","journal-title":"Neuroscience"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"Zorova L.D.","year":"2018","unstructured":"Zorova L.D.; Popkov V.A.; Plotnikov E.Y.; Silachev D.N.; Pevzner I.B.; Jankauskas S.S.; Babenko V.A.; Zorov S.D.; Balakireva A.V.; Juhaszova M.; Sollott S.J.; Zorov D.B.; Mitochondrial membrane potential. Anal Biochem 2018,552,50-59","journal-title":"Anal Biochem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.neuron.2012.03.032","volume":"74","author":"Gim&#xE9;nez-Cassina A.","year":"2012","unstructured":"Gim&#xE9;nez-Cassina A.; Mart&#xED;nez-Fran&#xE7;ois J.R.; Fisher J.K.; Szlyk B.; Polak K.; Wiwczar J.; Tanner G.R.; Lutas A.; Yellen G.; Danial N.N.; BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 2012,74(4),719-730","journal-title":"Neuron"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1126\/science.1059829","volume":"292","author":"Yamada K.","year":"2001","unstructured":"Yamada K.; Ji J.J.; Yuan H.; Miki T.; Sato S.; Horimoto N.; Shimizu T.; Seino S.; Inagaki N.; Protective role of ATP-sensitive potas-sium channels in hypoxia-induced generalized seizure. Science 2001,292(5521),1543-1546","journal-title":"Science"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1152\/jn.00970.2005","volume":"95","author":"Sun H.S.","year":"2006","unstructured":"Sun H.S.; Feng Z.P.; Miki T.; Seino S.; French R.J.; Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. J Neurophysiol 2006,95(4),2590-2601","journal-title":"J Neurophysiol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2018.11.008","volume":"151","author":"Weltha L.","year":"2019","unstructured":"Weltha L.; Reemmer J.; Boison D.; The role of adenosine in epilepsy. Brain Res Bull 2019,151,46-54","journal-title":"Brain Res Bull"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1523\/ENEURO.0385-18.2018","volume":"5","author":"Canas P.M.","year":"2018","unstructured":"Canas P.M.; Porci&#xFA;ncula L.O.; Sim&#xF5;es A.P.; Augusto E.; Silva H.B.; Machado N.J.; Gon&#xE7;alves N.; Alfaro T.M.; Gon&#xE7;alves F.Q.; Ara&#xFA;jo I.M.; Real J.I.; Coelho J.E.; Andrade G.M.; Almeida R.D.; Chen J.F.; K&#xF6;falvi A.; Agostinho P.; Cunha R.A.; Neuronal adeno-sine A2A receptors are critical mediators of neurodegeneration triggered by convulsions. eNeuro 2018,5(6),5","journal-title":"eNeuro"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/glia.22285","volume":"60","author":"Boison D.","year":"2012","unstructured":"Boison D.; Adenosine dysfunction in epilepsy. Glia 2012,60(8),1234-1243","journal-title":"Glia"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002100000314","volume":"362","author":"Haas H.L.","year":"2000","unstructured":"Haas H.L.; Selbach O.; Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 2000,362(4-5),375-381","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1172\/JCI57813","volume":"121","author":"Masino S.A.","year":"2011","unstructured":"Masino S.A.; Li T.; Theofilas P.; Sandau U.S.; Ruskin D.N.; Fredholm B.B.; Geiger J.D.; Aronica E.; Boison D.; A ketogenic diet suppresses seizures in mice through adenosine A\u2081; receptors. J Clin Invest 2011,121(7),2679-2683","journal-title":"J Clin Invest"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"Sheth S.","year":"2014","unstructured":"Sheth S.; Brito R.; Mukherjea D.; Rybak L.P.; Ramkumar V.; Adenosine receptors: Expression, function and regulation. Int J Mol Sci 2014,15(2),2024-2052","journal-title":"Int J Mol Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.3390\/nu13114082","volume":"13","author":"Brunner B.","year":"2021","unstructured":"Brunner B.; Ari C.; D\u2019Agostino D.P.; Kov&#xE1;cs Z.; Adenosine receptors modulate the exogenous ketogenic supplement-evoked alleviating effect on lipopolysaccharide-generated increase in absence epileptic activity in WAG\/Rij rats. Nutrients 2021,13(11),4082","journal-title":"Nutrients"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"191-197","DOI":"10.1002\/epi4.12251","volume":"3","author":"Shao L.R.","year":"2018","unstructured":"Shao L.R.; Rho J.M.; Stafstrom C.E.; Glycolytic inhibition: A novel approach toward controlling neuronal excitability and seizures. Epilepsia Open 2018,3((Suppl)(Suppl. 2)),191-197","journal-title":"Epilepsia Open"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2019.02.027","volume":"209","author":"Pinchefsky E.F.","year":"2019","unstructured":"Pinchefsky E.F.; Hahn C.D.; Kamino D.; Chau V.; Brant R.; Moore A.M.; Tam E.W.Y.; Hyperglycemia and glucose variability are associated with worse brain function and seizures in neonatal encephalopathy: A prospective cohort study. J Pediatr 2019,209,23-32","journal-title":"J Pediatr"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molmet.2014.03.002","volume":"3","author":"Kalsbeek A.","year":"2014","unstructured":"Kalsbeek A.; la Fleur S.; Fliers E.; Circadian control of glucose metabolism. Mol Metab 2014,3(4),372-383","journal-title":"Mol Metab"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21603","volume":"65","author":"Stafstrom C.E.","year":"2009","unstructured":"Stafstrom C.E.; Ockuly J.C.; Murphree L.; Valley M.T.; Roopra A.; Sutula T.P.; Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann Neurol 2009,65(4),435-447","journal-title":"Ann Neurol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1742-2094-11-58","volume":"11","author":"Vilalta A.","year":"2014","unstructured":"Vilalta A.; Brown G.C.; Deoxyglucose prevents neurodegeneration in culture by eliminating microglia. J Neuroinflammation 2014,11(1),58","journal-title":"J Neuroinflammation"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12463","volume":"44","author":"Marsan E.","year":"2018","unstructured":"Marsan E.; Baulac S.; Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 2018,44(1),6-17","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1523\/JNEUROSCI.2260-18.2019","volume":"39","author":"Nguyen L.H.","year":"2019","unstructured":"Nguyen L.H.; Mahadeo T.; Bordey A.; mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci 2019,39(14),2762-2773","journal-title":"J Neurosci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1494","volume":"37","author":"Inoki K.","year":"2005","unstructured":"Inoki K.; Corradetti M.N.; Guan K.L.; Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005,37(1),19-24","journal-title":"Nat Genet"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"106207","DOI":"10.1016\/j.eplepsyres.2019.106207","volume":"157","author":"Mazumder A.G.","year":"2019","unstructured":"Mazumder A.G.; Kumari S.; Singh D.; Anticonvulsant action of a selective phosphatidylinositol-3-kinase inhibitor LY294002 in pen-tylenetetrazole-mediated convulsions in zebrafish. Epilepsy Res 2019,157,106207","journal-title":"Epilepsy Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"Curatolo P.","year":"2015","unstructured":"Curatolo P.; Moavero R.; de Vries P.J.; Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015,14(7),733-745","journal-title":"Lancet Neurol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/acn3.50829","volume":"6","author":"Koene L.M.C.","year":"2019","unstructured":"Koene L.M.C.; van Grondelle S.E.; Proietti Onori M.; Wallaard I.; Kooijman N.H.R.M.; van Oort A.; Schreiber J.; Elgersma Y.; Effects of antiepileptic drugs in a new TSC\/mTOR-dependent epilepsy mouse model. Ann Clin Transl Neurol 2019,6(7),1273-1291","journal-title":"Ann Clin Transl Neurol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40538-020-00194-4","author":"Liu H.","year":"2020","unstructured":"Liu H.; Huang J.; Liu H.; Li F.; Peng Q.; Liu C.; Effects of ketogenic diet containing medium-chain fatty acids on serum inflammatory factor and mTOR signaling pathway in rats. Chem Biol Technol Agric 2020,7","journal-title":"Chem Biol Technol Agric"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"23617","DOI":"10.1073\/pnas.2008980117","volume":"117","author":"Warren E.C.","year":"2020","unstructured":"Warren E.C.; Dooves S.; Lugar&#xE0; E.; Damstra-Oddy J.; Schaf J.; Heine V.M.; Walker M.C.; Williams R.S.B.; Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling. Proc Natl Acad Sci USA 2020,117(38),23617-23625","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13578-021-00611-7","volume":"11","author":"Wang J.","year":"2021","unstructured":"Wang J.; Huang J.; Yao S.; Wu J.H.; Li H.B.; Gao F.; Wang Y.; Huang G.B.; You Q.L.; Li J.; Chen X.; Sun X.D.; The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity. Cell Biosci 2021,11(1),93","journal-title":"Cell Biosci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuroscience.2017.09.056","volume":"366","author":"Wang X.","year":"2017","unstructured":"Wang X.; Wu X.; Liu Q.; Kong G.; Zhou J.; Jiang J.; Wu X.; Huang Z.; Su W.; Zhu Q.; Ketogenic metabolism inhibits histone deacetylase (HDAC) and reduces oxidative stress after spinal cord injury in rats. Neuroscience 2017,366,36-43","journal-title":"Neuroscience"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","volume":"69","author":"Chang P.","year":"2013","unstructured":"Chang P.; Terbach N.; Plant N.; Chen P.E.; Walker M.C.; Williams R.S.; Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology 2013,69,105-114","journal-title":"Neuropharmacology"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","volume":"17","author":"Shen H.H.","year":"2018","unstructured":"Shen H.H.; Yang Y.X.; Meng X.; Luo X.Y.; Li X.M.; Shuai Z.W.; Ye D.Q.; Pan H.F.; NLRP3: A promising therapeutic target for auto-immune diseases. Autoimmun Rev 2018,17(7),694-702","journal-title":"Autoimmun Rev"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"Shippy D.C.","year":"2020","unstructured":"Shippy D.C.; Wilhelm, C.; Viharkumar, P.A.; Raife, T.J.; Ulland, T.K. &#x3B2;;-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation 2020,17(1),280","journal-title":"J Neuroinflammation"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnmol.2018.00086","volume":"11","author":"Guo M.","year":"2018","unstructured":"Guo M.; Wang X.; Zhao Y.; Yang Q.; Ding H.; Dong Q.; Chen X.; Cui M.; Ketogenic diet improves brain ischemic tolerance and inhib-its NLRP3 inflammasome activation by preventing Drp1-mediated mitochondrial fission and endoplasmic reticulum stress. Front Mol Neurosci 2018,11,86","journal-title":"Front Mol Neurosci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ebiom.2019.05.024","volume":"44","author":"Dahlin M.","year":"2019","unstructured":"Dahlin M.; Prast-Nielsen S.; The gut microbiome and epilepsy. EBioMedicine 2019,44,741-746","journal-title":"EBioMedicine"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphys.2011.00094","volume":"2","author":"Grenham S.","year":"2011","unstructured":"Grenham S.; Clarke G.; Cryan J.F.; Dinan T.G.; Brain-gut-microbe communication in health and disease. Front Physiol 2011,2,94","journal-title":"Front Physiol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"106409","DOI":"10.1016\/j.eplepsyres.2020.106409","volume":"166","author":"Pittman Q.J.","year":"2020","unstructured":"Pittman Q.J.; A gut feeling about the ketogenic diet in epilepsy. Epilepsy Res 2020,166,106409","journal-title":"Epilepsy Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.3748\/wjg.v23.i33.6164","volume":"23","author":"Xie G.","year":"2017","unstructured":"Xie G.; Zhou Q.; Qiu C.Z.; Dai W.K.; Wang H.P.; Li Y.H.; Liao J.X.; Lu X.G.; Lin S.F.; Ye J.H.; Ma Z.Y.; Wang W.J.; Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy. World J Gastroenterol 2017,23(33),6164-6171","journal-title":"World J Gastroenterol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.csbj.2019.09.008","volume":"17","author":"Lin C.","year":"2019","unstructured":"Lin C.; Zhao S.; Zhu Y.; Fan Z.; Wang J.; Zhang B.; Chen Y.; Microbiota-gut-brain axis and toll-like receptors in Alzheimer\u2019s disease. Comput Struct Biotechnol J 2019,17,1309-1317","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1152\/ajpendo.00015.2017","volume":"314","author":"Panasevich M.R.","year":"2018","unstructured":"Panasevich M.R.; Meers G.M.; Linden M.A.; Booth F.W.; Perfield J.W.; Fritsche K.L.; Wankhade U.D.; Chintapalli S.V.; Shankar K.; Ibdah J.A.; Rector R.S.; High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juve-nile Ossabaw swine. Am J Physiol Endocrinol Metab 2018,314(1),E78-E92","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yebeh.2018.12.010","volume":"93","author":"Roehl K.","year":"2019","unstructured":"Roehl K.; Falco-Walter J.; Ouyang B.; Balabanov A.; Modified ketogenic diets in adults with refractory epilepsy: Efficacious improve-ments in seizure frequency, seizure severity, and quality of life. Epilepsy Behav 2019,93,113-118","journal-title":"Epilepsy Behav"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fncel.2018.00274","volume":"12","author":"McDonald T.","year":"2018","unstructured":"McDonald T.; Puchowicz M.; Borges K.; Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof. Front Cell Neurosci 2018,12,274","journal-title":"Front Cell Neurosci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13760-016-0601-x","volume":"116","author":"Zamani G.R.","year":"2016","unstructured":"Zamani G.R.; Mohammadi M.; Ashrafi M.R.; Karimi P.; Mahmoudi M.; Badv R.S.; Tavassoli A.R.; Azizi Malamiri R.; The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol Belg 2016,116(4),529-534","journal-title":"Acta Neurol Belg"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.seizure.2010.11.010","volume":"20","author":"Miranda M.J.","year":"2011","unstructured":"Miranda M.J.; Mortensen M.; Povlsen J.H.; Nielsen H.; Beniczky S.; Danish study of a modified Atkins diet for medically intractable epilepsy in children: Can we achieve the same results as with the classical ketogenic diet? Seizure 2011,20(2),151-155","journal-title":"Seizure"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-277X.2010.01040.x","volume":"23","author":"Lord K.","year":"2010","unstructured":"Lord K.; Magrath G.; Use of the ketogenic diet and dietary practices in the UK. J Hum Nutr Diet 2010,23(2),126-132","journal-title":"J Hum Nutr Diet"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.2147\/NDT.S201862","volume":"15","author":"Goswami J.N.","year":"2019","unstructured":"Goswami J.N.; Sharma S.; Current perspectives on the role of the ketogenic diet in epilepsy management. Neuropsychiatr Dis Treat 2019,15,3273-3285","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1528-1167.2012.03406.x","volume":"53","author":"Cervenka M.C.","year":"2012","unstructured":"Cervenka M.C.; Terao N.N.; Bosarge J.L.; Henry B.J.; Klees A.A.; Morrison P.F.; Kossoff E.H.; E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective. Epilepsia 2012,53(4),728-732","journal-title":"Epilepsia"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.eplepsyres.2012.06.007","volume":"100","author":"Miranda M.J.","year":"2012","unstructured":"Miranda M.J.; Turner Z.; Magrath G.; Alternative diets to the classical ketogenic diet--can we be more liberal? Epilepsy Res 2012,100(3),278-285","journal-title":"Epilepsy Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"106319","DOI":"10.1016\/j.eplepsyres.2020.106319","volume":"162","author":"Husari K.S.","year":"2020","unstructured":"Husari K.S.; Cervenka M.C.; The ketogenic diet all grown up-Ketogenic diet therapies for adults. Epilepsy Res 2020,162,106319","journal-title":"Epilepsy Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/088307380101600901","volume":"16","author":"Wheless J.W.","year":"2001","unstructured":"Wheless J.W.; The ketogenic diet: An effective medical therapy with side effects. J Child Neurol 2001,16(9),633-635","journal-title":"J Child Neurol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"CNS17","DOI":"10.2217\/cns-2017-0030","volume":"7","author":"Martin-McGill K.J.","year":"2018","unstructured":"Martin-McGill K.J.; Srikandarajah N.; Marson A.G.; Tudur Smith C.; Jenkinson M.D.; The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: A systematic review. CNS Oncol 2018,7(2),CNS17","journal-title":"CNS Oncol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fnins.2019.01041","volume":"13","author":"Poff A.M.","year":"2019","unstructured":"Poff A.M.; Rho J.M.; D\u2019Agostino D.P.; Ketone administration for seizure disorders: History and rationale for ketone esters and metabolic alternatives. Front Neurosci 2019,13,1041","journal-title":"Front Neurosci"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-017-0053-2","volume":"13","author":"Cai Q.Y.","year":"2017","unstructured":"Cai Q.Y.; Zhou Z.J.; Luo R.; Gan J.; Li S.P.; Mu D.Z.; Wan C.M.; Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: A systematic review of published prospective studies. World J Pediatr 2017,13(6),528-536","journal-title":"World J Pediatr"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.yapd.2010.08.003","volume":"57","author":"Freeman J.M.","year":"2010","unstructured":"Freeman J.M.; Kossoff E.H.; Ketosis and the ketogenic diet, 2010: Advances in treating epilepsy and other disorders. Adv Pediatr 2010,57(1),315-329","journal-title":"Adv Pediatr"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1203\/01.PDR.0000112032.47575.D1","volume":"55","author":"Zhao Q.","year":"2004","unstructured":"Zhao Q.; Stafstrom C.E.; Fu D.D.; Hu Y.; Holmes G.L.; Detrimental effects of the ketogenic diet on cognitive function in rats. Pediatr Res 2004,55(3),498-506","journal-title":"Pediatr Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1152\/ajpendo.00453.2013","volume":"306","year":"2014","unstructured":"Ellenbroek, J.H. van,Dijck, L.;T&#xF6;ns, H.A.;Rabelink, T.J.;Carlotti, F.;Ballieux, B.E.; de Koning, E.J. Long-term ketogenic diet causes glucose intolerance and reduced &#x3B2;-and &#x3B1;-cell mass but no weight loss in mice. Am J Physiol Endocrinol Metab 2014,306,E552-E558","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1212\/WNL.54.12.2328","volume":"54","author":"Best T.H.","year":"2000","unstructured":"Best T.H.; Franz D.N.; Gilbert D.L.; Nelson D.P.; Epstein M.R.; Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000,54(12),2328-2330","journal-title":"Neurology"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.pediatrneurol.2008.08.013","volume":"39","author":"Bank I.M.","year":"2008","unstructured":"Bank I.M.; Shemie S.D.; Rosenblatt B.; Bernard C.; Mackie A.S.; Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol 2008,39(6),429-431","journal-title":"Pediatr Neurol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7499\/j.issn.1008-8830.2019.05.010","volume":"21","author":"Chen H.","year":"2019","unstructured":"Chen H.; Chen Y.H.; Liu L.; Wang Y.; Effects of ketogenic diet on lipid metabolism in children with intractable epilepsy. Zhongguo Dang Dai Er Ke Za Zhi 2019,21(5),450-453","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/08998280.2019.1664220","volume":"33","author":"Sudhakaran S.","year":"2019","unstructured":"Sudhakaran S.; Yazdani L.; Wheelan K.R.; Rao P.K.; The ketogenic diet and the QT interval. Proc Bayl Univ Med Cent 2019,33(1),77-79","journal-title":"Proc Bayl Univ Med Cent"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jocn.2011.05.012","volume":"19","author":"Sharma S.","year":"2012","unstructured":"Sharma S.; Gulati S.; The ketogenic diet and the QT interval. J Clin Neurosci 2012,19(1),181-182","journal-title":"J Clin Neurosci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3349\/ymj.2010.51.3.457","volume":"51","author":"Choi J.N.","year":"2010","unstructured":"Choi J.N.; Song J.E.; Shin J.I.; Kim H.D.; Kim M.J.; Lee J.S.; Renal stone associated with the ketogenic diet in a 5-year old girl with intractable epilepsy. Yonsei Med J 2010,51(3),457-459","journal-title":"Yonsei Med J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/0883073807301926","volume":"22","author":"Sampath A.","year":"2007","unstructured":"Sampath A.; Kossoff E.H.; Furth S.L.; Pyzik P.L.; Vining E.P.; Kidney stones and the ketogenic diet: Risk factors and prevention. J Child Neurol 2007,22(4),375-378","journal-title":"J Child Neurol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1542\/peds.2009-0217","volume":"124","author":"McNally M.A.","year":"2009","unstructured":"McNally M.A.; Pyzik P.L.; Rubenstein J.E.; Hamdy R.F.; Kossoff E.H.; Empiric use of potassium citrate reduces kidney-stone inci-dence with the ketogenic diet. Pediatrics 2009,124(2),e300-e304","journal-title":"Pediatrics"},{"key":"ref=150","first-page":"27","volume":"26","year":"2018","unstructured":"Dudzi\u0144;ska, M. Ketogenic diet in epilepsy: An updated review. J Epilepsy Res 2018,26,27-47","journal-title":"J Epilepsy Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","volume":"3","author":"Kossoff E.H.","year":"2018","unstructured":"Kossoff E.H.; Zupec-Kania B.A.; Auvin S.; Ballaban-Gil K.R.; Christina Bergqvist A.G.; Blackford R.; Buchhalter J.R.; Caraballo R.H.; Cross J.H.; Dahlin M.G.; Donner E.J.; Guzel O.; Jehle R.S.; Klepper J.; Kang H.C.; Lambrechts D.A.; Liu Y.M.C.; Nathan J.K.; Nordli D.R.; Pfeifer H.H.; Rho J.M.; Scheffer I.E.; Sharma S.; Stafstrom C.E.; Thiele E.A.; Turner Z.; Vaccarezza M.M.; van der Louw E.J.T.M.; Veggiotti P.; Wheless J.W.; Wirrell E.C.; Optimal clinical management of children receiving dietary therapies for epilep-sy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018,3(2),175-192","journal-title":"Epilepsia Open"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X20666220420130109","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203851\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X20666220420130109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T18:54:35Z","timestamp":1727031275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203851\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":151,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x20666220420130109","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}